FutureChem Co.,Ltd
220100.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$163.18B
Close$
Share Statistics
| Market cap | $163.18 Billion |
|---|---|
| Enterprise Value | $163.88 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-508.31 |
| Beta | 0.64 |
| Outstanding Shares | 23,179,034 |
Return
| Return on Equity | -20.29% |
|---|---|
| Return on Assets | -16.29% |
| Return on Invested Capital | -16.74% |
Valuation & Multiples
| P/E Ratio | -13.86 |
|---|---|
| PEG | 127.29 |
| Price to Sales | 7.36 |
| Price to Book Ratio | 2.75 |
| Enterprise Value to Revenue | 7.96 |
| Enterprise Value to EBIT | -16.42 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About FutureChem Co.,Ltd
66 employees
CEO: Dae-Yoon Chi FutureChem Co.,Ltd is a South Korean company dedicated to the creation and distribution of radiopharmaceutical products. Its current offerings include PDVUE, a positron emission tomography (PET) diagnostic agent for Parkinson's disease; ...